Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553136 · ClinicalTrials.gov registry record · Phase 2
Varenicline Treatment of Alcohol Dependence in Smokers
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
NCT01553136: Completed Phase 2 study, sponsored by Yale University.
NCT01553136 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 131 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01553136, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether varenicline is effective in the treatment of alcohol dependence in smokers.
Primary Outcome
The percentage of days of heavy drinking will be examined over the final 8 weeks of the study averaged by month (weeks 9-12 and weeks 13-16). A heavy drinking day is defined as 5 or more standard drinks for men and 4 or more standard drinks for women. A standard drink contains approximately 0.6 fluid ounces of pure alcohol.
Interventions
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
What the finished NCT01553136 record still lists
NCT01553136 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Varenicline is the first listed.
NCT01553136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01553136 about?
NCT01553136 is a clinical study titled "Varenicline Treatment of Alcohol Dependence in Smokers". The purpose of this study is to determine whether varenicline is effective in the treatment of alcohol dependence in smokers.
What is the current status of trial NCT01553136?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2012-09. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01553136?
The interventions under investigation include: Varenicline (DRUG).
Who is sponsoring clinical trial NCT01553136?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01553136's enrollment target sits among peer trials
131 541st of 2000 higher than 1,458 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia